"Hôpital Polyvalent à l'Est Parisien, géré par la Fondation Cognacq-Jay."

During the past decade, Hôpital Forcilles conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Forcilles" #1 sponsor was "Hopital Forcilles" with 5 trials, followed by "Groupe Hospitalier Paris Saint Joseph" with 2 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 1 trials sponsored, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials sponsored and "Hopital Foch" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Forcilles" #1 collaborator was "Hopital Forcilles" with 2 trials as a collaborator, "AIO-Studien-gGmbH" with 1 trials as a collaborator, "Centre Hospitalier Universitaire Dijon" with 1 trials as a collaborator, "Grupo Español de Tratamiento de Tumores de Cabeza y Cuello" with 1 trials as a collaborator and "St Vincent's Hospital, Sydney" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Forcilles" are "Obesity" (2 trials), "Weaning Failure" (2 trials), "COVID-19" (1 trials), "Colorectal Cancer" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "Hôpital Forcilles" in a lesser frequency.

Most popular intervention types in "Hôpital Forcilles" are "Diagnostic Test" (4 trials), "Device" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracile" (1 trials), "Associated factors with decannulation" (1 trials), "Cetuximab" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Forcilles" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Forcilles". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Forcilles, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Forcilles, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".